Efavirenz therapeutic range in HIV-1 treatment-naive participants

Keyphrases

• Treatment-naïve 100%
• Efavirenz 100%
• Therapeutic Range 100%
• HIV-1 Treatment 100%
• Virological Failure 80%
• Race-ethnicity 30%
• Plasma Concentration 30%
• Adverse Effects 10%
• United States 10%
• Human Immunodeficiency Virus Type 1 (HIV-1) 10%
• Univariate Analysis 10%
• HIV Patients 10%
• Logistic Regression Analysis 10%
• High Concentration 10%
• Health Departments 10%
• Group Studies 10%
• Dose Rate 10%
• Non-Hispanic White 10%
• Antiretroviral Regimens 10%
• HIV RNA 10%
• Patient Weight 10%
• AIDS Clinical Trials 10%
• Health Care Services 10%
• Drug Screening 10%
• Group 11 10%
• Concentration Value 10%
• Lower Limit 10%
• Intravenous Drug Use 10%
• Group 12 10%
• Human Services 10%
• Range Effect 10%
• Antiretroviral Naïve 10%
• Appropriate Concentration 10%
• Nucleos(t)ide Analogues 10%
• Divided Subject 10%
• Reverse Transcriptase Inhibitors 10%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Efavirenz 100%
• Clinical Trial 10%
• Univariate Analysis 10%
• Logistic Regression Analysis 10%
• Drug Use 10%
• Reverse-Transcriptase Inhibitor 10%
• Drug Screening 10%
• Adverse Effect 10%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Efavirenz 100%
• Clinical Trial 10%
• RNA Directed DNA Polymerase Inhibitor 10%